APYX Medical study shows Renuvion improves liposuction outcomes
Go back to APYX Medical study shows Renuvion improves liposuction outcomes| (NASDAQ: APYX) | Delayed: 3.96 -0.05 (1.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.01 | 52 Week High | $ | |||
| Open | $3.95 | 52 Week Low | $ | |||
| Day High | $4.08 | P/E | N/A | |||
| Day Low | $3.95 | EPS | $ | |||
| Volume | 28,579 | |||||

